BeyondAirInc . (NASDAQ:XAIR) released its quarterly earnings data on Wednesday. The company reported ($0.38) earnings per share for the quarter, missing the consensus estimate of ($0.30) by ($0.08), Fidelity Earnings reports. The firm had revenue of $0.65 million for the quarter, compared to the consensus estimate of $0.63 million.
XAIR stock traded down $0.15 during midday trading on Friday, reaching $4.09. 25 shares of the company’s stock traded hands, compared to its average volume of 3,697. The firm has a market capitalization of $45.46 million, a P/E ratio of -5.05 and a beta of -0.29. The firm has a fifty day simple moving average of $4.51. BeyondAirInc . has a 52 week low of $3.11 and a 52 week high of $6.25.
Several research firms have recently weighed in on XAIR. Oppenheimer began coverage on shares of BeyondAirInc . in a research note on Tuesday, October 22nd. They issued an “outperform” rating and a $9.00 price objective for the company. Zacks Investment Research lowered shares of BeyondAirInc . from a “hold” rating to a “sell” rating in a research note on Saturday, October 19th. Finally, ValuEngine lowered shares of BeyondAirInc . from a “buy” rating to a “hold” rating in a research note on Wednesday, October 30th.
Beyond Air, Inc, a clinical-stage medical device and biopharmaceutical company, develops nitric oxide (NO) delivery systems to treat respiratory tract infections and other diseases. Its NO delivery systems are used for the treatment of pulmonary hypertension of the newborn, bronchiolitis, and nontuberculous mycobacteria.
Further Reading: Average Daily Trade Volume – ADTV
Receive News & Ratings for BeyondAirInc . Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BeyondAirInc . and related companies with MarketBeat.com's FREE daily email newsletter.